ReNeuron Group Plc Company Profile (LON:RENE)

About ReNeuron Group Plc

ReNeuron Group Plc logoReNeuron Group plc is a clinical-stage company. The Company, through its subsidiaries, is engaged in researching and developing cell-based therapies. The Company's products are allogeneic. Its CTX stem cell therapy is used for the treatment of patients left disabled by the effects of a stroke. Its human retinal progenitor cells (hRPC) stem cell candidate is used for the treatment of retinitis pigmentosa (RP). Its second CTX stem cell candidate is for the treatment of critical limb ischaemia. The Company's exosomes nanomedicine platform focuses on generating early pre-clinical data in cancer. Its ReNcell Products include ReNcellVM and ReNcellCX cell lines. It is engaged in Phase II clinical trial of CTX cells for stroke disability. It is engaged in Phase I clinical trial of CTX cells for Critical Limb Ischaemia. It is engaged in Phase I clinical trial of hRPC stem cell candidate. The Company has completed pre-clinical trials CTX-derived exosomes.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: RENE
  • CUSIP:
Key Metrics:
  • Previous Close: $0.03
  • 50 Day Moving Average: $2.575
  • 200 Day Moving Average: $2.640
  • 52-Week Range: GBX 2.25 - GBX 3.87
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $76.74M
  • Outstanding Shares: 3,164,618,000
Additional Links:

Analyst Ratings

Consensus Ratings for ReNeuron Group Plc (LON:RENE) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 9

Analysts' Ratings History for ReNeuron Group Plc (LON:RENE)
Show:
DateFirmActionRatingPrice TargetDetails
1/4/2017N+1 SingerReiterated RatingBuyGBX 9View Rating Details
9/6/2016Stifel NicolausReiterated RatingBuyView Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for ReNeuron Group Plc (LON:RENE)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for ReNeuron Group Plc (LON:RENE)
Current Year EPS Consensus Estimate: $-0.730 EPS

Dividends

Dividend History for ReNeuron Group Plc (LON:RENE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ReNeuron Group Plc (LON:RENE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/7/2017Michael HuntInsiderBuy250,000GBX 3£7,500
2/17/2016Hunt,MichaelInsiderSell509,554GBX 3£15,286.62
2/12/2016Hunt,MichaelInsiderSell594,637GBX 3£17,839.11
2/11/2016Hunt,MichaelInsiderSell1,208,333GBX 3£36,249.99
2/5/2016Hunt,MichaelInsiderSell1,035,533GBX 3£31,065.99
2/2/2016Edward Berriman,JohnInsiderBuy318,476GBX 3£9,554.28
1/29/2015Olav HellebøInsiderBuy322,778GBX 3.10£10,006.12
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ReNeuron Group Plc (LON:RENE)
DateHeadline
News IconFollowing the Numbers for ReNeuron Group PLC (RENE.L) - Rives Journal (LON:RENE)
rivesjournal.com - February 24 at 8:07 AM
News IconRetinitis Pigmentosa (RP) Market – The Biggest Trends to Watch out for 2017 – 2025 (LON:RENE)
empowerednews.net - February 23 at 7:38 PM
proactiveinvestors.co.uk logoA robust performance from Lloyds, reckons Hunter - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 23 at 8:31 AM
proactiveinvestors.co.uk logo'We see enormous potential going forward', says Avation's Richard Wolanski - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 23 at 8:31 AM
proactiveinvestors.co.uk logo'Rocket launcher' technicals could see Redx Pharma shares double - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 23 at 8:31 AM
proactiveinvestors.co.uk logo'We're really bringing this project along' says Asiamet's Steve Hughes - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 23 at 8:31 AM
proactiveinvestors.co.uk logoFed minutes review: Just how soon is “fairly soon”? - Tip TV - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 23 at 8:31 AM
proactiveinvestors.co.uk logoIplayco's Max Liszkowski looking ahead to a 'very good' financial year - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 23 at 8:31 AM
proactiveinvestors.co.uk logoDeltex Medical Group chief says monitor sales good for cash balance - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 23 at 8:31 AM
proactiveinvestors.co.uk logoNetScientific boss proud of cancer diagnostic tool's achievements - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 23 at 8:30 AM
proactiveinvestors.co.uk logoVast Resources 'survives a few challenging months quite nicely', says CEO Roy Pitchford - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 22 at 9:32 AM
proactiveinvestors.co.uk logo'There's an awful lot to play for' - Cenkos analyst on 88 Energy's Icewine potential - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 22 at 9:32 AM
proactiveinvestors.co.uk logoAnglo Pacific's Julian Treger talks of 'very positive' shareholder response to uranium acquisition - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 22 at 9:32 AM
proactiveinvestors.co.uk logoAbzena sees 'strong momentum right across the business' during 2016, says CEO Dr John Burt - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 22 at 9:32 AM
proactiveinvestors.co.uk logoLloyds is looking like a "fairly stable bank", reckons Hunter - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 22 at 9:32 AM
proactiveinvestors.co.uk logoAll eyes on the Fed minutes - Tip TV - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 22 at 9:32 AM
proactiveinvestors.co.uk logoCan Amryt Pharma add 75% to its share price? - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 22 at 9:32 AM
openpr.com logoStem Cell Therapy Market Worth USD 60.94 Billion by 2022 (LON:RENE)
www.openpr.com - February 20 at 9:11 AM
News IconBBC Two's Hospital recommissioned for two more series (LON:RENE)
www.newsoneplace.com - February 16 at 7:10 PM
News IconBBC Two's Hospital recommissioned for two more series (LON:RENE)
www.newsoneplace.com - February 16 at 7:10 PM
News IconReNeuron featured in BBC documentary - Satellite PR News (press release) (LON:RENE)
www.satprnews.com - February 15 at 5:41 AM
proactiveinvestors.co.uk logoReNeuron makes a guest appearance on BBC2 - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - February 15 at 5:41 AM
News IconInvesting Focus: Indicators in View on Shares of ReNeuron Group PLC (RENE.L) - Rives Journal (LON:RENE)
rivesjournal.com - February 13 at 8:53 AM
News IconShare Focus: Watching Levels for ReNeuron Group PLC (RENE.L) - The Standard (LON:RENE)
6milestandard.com - February 10 at 10:28 PM
biz.yahoo.com logoHalf Year 2016 ReNeuron Group PLC Earnings Release - Before Market Open (LON:RENE)
biz.yahoo.com - February 10 at 10:28 PM
publicnow.com logoReNeuron Group plc Interim Statement 2016 (LON:RENE)
www.publicnow.com - February 10 at 10:28 PM
News IconStock Check: Reviewing the Numbers for ReNeuron Group PLC (RENE.L) - Baldwin Journal (LON:RENE)
baldwinjournal.com - February 9 at 3:52 AM
News IconDirector Share Purchase – SAT Press Releases - satPRNews - Satellite PR News (press release) (LON:RENE)
www.satprnews.com - February 8 at 4:02 AM
News IconStock Momentum in Focus on Shares of ReNeuron Group PLC (RENE.L) - Davidson Register (LON:RENE)
davidsonregister.com - February 8 at 4:02 AM
News IconRetinitis Pigmentosa Market Outlook, Competitive Analysis and Industry Survey 2025 (LON:RENE)
www.ssuchronicle.com - February 7 at 11:00 PM
News IconDirector Deals - ReNeuron Group PLC (RENE) (LON:RENE)
www.youinvest.co.uk - February 7 at 11:00 PM
openpr.com logoThe report provides comprehensive and reliable information on the Retinitis Pigmentosa (RP) Market 2017 - 2025 (LON:RENE)
www.openpr.com - February 7 at 8:21 AM
morningstar.co.uk logoDIRECTOR DEALINGS: ReNeuron CFO Buys 250,000 Shares (LON:RENE)
www.morningstar.co.uk - February 7 at 8:21 AM
News IconEquity Insight: Indicator Review for ReNeuron Group PLC (RENE.L) - Springdale Times (LON:RENE)
springdaletimes.com - January 27 at 2:08 AM
News IconTrading Scope: Indicator Review for ReNeuron Group PLC (RENE.L) - Springdale Times (LON:RENE)
springdaletimes.com - January 24 at 12:52 AM
News IconEquity Rundown: RSI and CCI Check on ReNeuron Group PLC (RENE.L) - Springdale Times (LON:RENE)
springdaletimes.com - January 20 at 6:28 AM
News IconTrading Views: RSI, MA, and ADX Review for ReNeuron Group PLC (RENE.L) - Springdale Times (LON:RENE)
springdaletimes.com - January 18 at 8:07 AM
News IconMarket Rover: Looking at Levels on Shares of ReNeuron Group PLC (RENE.L) - Springdale Times (LON:RENE)
springdaletimes.com - January 17 at 7:53 PM
morningstar.co.uk logoEvgen Pharma Doses First Breast Cancer Trial Patients; Hires New CFO (LON:RENE)
www.morningstar.co.uk - January 17 at 12:18 PM
trustnet.com logoAppointment of CFO and Head of Clinical Operations (LON:RENE)
www.trustnet.com - January 17 at 12:18 PM
proactiveinvestors.co.uk logoRare Earth Minerals shares to 're-test highs 2016 highs' - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - January 6 at 8:24 PM
proactiveinvestors.co.uk logoTissue Regenix enters key growth phase, chief exec Odell says - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - January 6 at 8:24 PM
proactiveinvestors.co.uk logoShore Capital's Mensah: Next needs to address intrinsic and ... - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - January 6 at 1:26 AM
proactiveinvestors.co.uk logoUS equity markets will not outperform this year - Henderson's James ... - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - January 6 at 1:26 AM
proactiveinvestors.co.uk logoThe Share Centre's Miah on Next: "very tough" environment for UK retailers post-Brexit - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - January 5 at 1:39 AM
proactiveinvestors.co.uk logoScancell "very optimistic" about US study after "compelling" melanoma trial results (LON:RENE)
www.proactiveinvestors.co.uk - January 4 at 8:14 PM
proactiveinvestors.co.uk logoVolitionRx chief hails importance of colorectal cancer screening test CE mark (LON:RENE)
www.proactiveinvestors.co.uk - January 3 at 9:58 AM
proactiveinvestors.co.uk logoITV a 'value play' as we head into 2017, says Zak Mir - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - January 2 at 8:15 AM
proactiveinvestors.co.uk logoZinc and copper still best of the base metals - Proactive Investors UK - Proactive Investors UK (LON:RENE)
www.proactiveinvestors.co.uk - January 1 at 12:21 AM
proactiveinvestors.co.uk logo2016 a 'tumultuous' year, says Michelle McGrade of TD Investing (LON:RENE)
www.proactiveinvestors.co.uk - December 31 at 7:20 PM

Social

What is ReNeuron Group Plc's stock symbol?

ReNeuron Group Plc trades on the London Stock Exchange (LON) under the ticker symbol "RENE."

Where is ReNeuron Group Plc's stock going? Where will ReNeuron Group Plc's stock price be in 2017?

2 brokers have issued twelve-month price objectives for ReNeuron Group Plc's shares. Their predictions range from GBX 9 to GBX 9. On average, they expect ReNeuron Group Plc's share price to reach GBX 9 in the next twelve months.

How do I buy ReNeuron Group Plc stock?

Shares of ReNeuron Group Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of ReNeuron Group Plc stock cost?

One share of ReNeuron Group Plc stock can currently be purchased for approximately GBX 2.43.


Last Updated on 2/25/2017 by MarketBeat.com Staff